Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cancer Letters
|
June 14, 2024
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S Fleishman, et al.
Drug Discovery Today
|
April 1, 2023
Advances in receptor chromatography for drug discovery and drug-receptor interaction studies
Jia Fu, Wei Qin, Lu-Qi Cao, et al.
Cancer Genetics
|
May 27, 2026
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process
Hong-Jian Ling, Jia-Li Zhou, Lu-Qi Cao, et al.
Frontiers in Pharmacology
|
February 8, 2024
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Cancer Genetics
|
December 11, 2025
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cells
Lu-Qi Cao, Yuhao Xie, Xuanyu Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 8, 2024
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
Da-Qian Chen, Yuhao Xie, Lu-Qi Cao, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2023
Nivolumab and relatlimab for the treatment of melanoma
Xuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 26, 2026
Emerging trends and converging evidence in tumor evolution: A comprehensive review
Chenqi Jin, Weiqi Li, Boqiang Liu, et al.
Molecular Cancer
|
August 1, 2025
Traditional Chinese medicine in the treatment of breast Cancer
Peng Song, Tongtong Liu, Yinfang Zhang, et al.
Frontiers in Pharmacology
|
March 21, 2019
Research Progress on PARP14 as a Drug Target
Wei Qin, Hong-Jie Wu, Lu-Qi Cao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cancer Letters
|
June 14, 2024
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S Fleishman, et al.
Drug Discovery Today
|
April 1, 2023
Advances in receptor chromatography for drug discovery and drug-receptor interaction studies
Jia Fu, Wei Qin, Lu-Qi Cao, et al.
Cancer Genetics
|
May 27, 2026
TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process
Hong-Jian Ling, Jia-Li Zhou, Lu-Qi Cao, et al.
Frontiers in Pharmacology
|
February 8, 2024
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Cancer Genetics
|
December 11, 2025
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cells
Lu-Qi Cao, Yuhao Xie, Xuanyu Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 8, 2024
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
Da-Qian Chen, Yuhao Xie, Lu-Qi Cao, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2023
Nivolumab and relatlimab for the treatment of melanoma
Xuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 26, 2026
Emerging trends and converging evidence in tumor evolution: A comprehensive review
Chenqi Jin, Weiqi Li, Boqiang Liu, et al.
Molecular Cancer
|
August 1, 2025
Traditional Chinese medicine in the treatment of breast Cancer
Peng Song, Tongtong Liu, Yinfang Zhang, et al.
Frontiers in Pharmacology
|
March 21, 2019
Research Progress on PARP14 as a Drug Target
Wei Qin, Hong-Jie Wu, Lu-Qi Cao, et al.
Page
of 2